Skip to main content
. 2017 Apr 15;8(4):154–164. doi: 10.4239/wjd.v8.i4.154

Table 3.

Differences between Study Phases for Biochemical and Anthropometric Parameters

Measurement Mean ± SD Phase 1 Mean ± SD Phase 2 Mean ± SD Phase 3 Mean difference Phase 1 to 2 Mean difference Phase 2 to 3 Mean difference Phase 1 to 3
Clinical outcome
Weight (kg) 100.6 ± 21.7 99.2 ± 21.3 99.5 ± 21.5 -1.4 (P = 0.009) +0.28 (P = 1.0) -1.12 (P = 0.08)
BMI (kg/m2) 36.9 ± 8.3 36.4 ± 8.1 36.5 ± 8.1 -0.52 (P = 0.01) +0.1 (P = 1.0) -0.42 (P = 0.09)
Waist circumference (cm) 109.6 ± 11.1 107.8 ± 11.1 107.5 ± 10.9 -1.75 (P = 0.086) -0.30 (P = 1.0) -2.05 (P = 0.24)
Systolic BP (mmHg) 130.0 ± 17.8 127.0 ± 21.4 128.5 ± 14.3 -3 (P = 0.83) +1.5 (P = 1.0) -1.5 (P = 1.0)
Diastolic BP (mmHg) 80.5 ± 13.2 79.8 ± 15.7 81.7 ± 12.2 -0.72 (P = 1.0) +1.9 (P = 0.76) +1.2 (P = 1.0)
Daily hours fasted 11.6 ± 1.9 16.8 ± 1.2 11.5 ± 2.0 +5.2 (P < 0.005) -5.3 (P < 0.005) -0.09 (P = 1.0)
Biochemical outcome
C-reactive protein (mg/L) 4.3 ± 3.8 4.0 ± 3.7 4.1 ± 3.5 -0.3 (P = 0.9) +0.09 (P = 1.0) -0.25 (P = 1.0)
HOMA-IR 6.9 ± 3.0 6.5 ± 2.4 6.6 ± 3.0 -0.46 (P = 1.0) +0.11 (P = 1.0) -0.35 (P = 1.0)

HOMA-IR: Homeostasis Model Assessment; BMI: Body mass index; BP: Blood pressure.